Clover Corporation’s (ASX:CLV) N3RO trial shows improvement in IQ of premature infants
Clover Corporation (CLV) announces the release of new results from its clinical…
Mon, 19 May | Last | Change |
12:15pm | 8,334.8 | 8.90 |
Currently Trading at Mon, 19 May 12:17pm |
S&P/ASX Sm. Ords. | 3,167.0 | 11.2 | 0.35% |
All Ordinaries | 8,568.2 | 11.7 | 0.14% |
S&P/ASX 100 | 7,006.5 | 7.00 | 0.10% |
XAM | XANADU MINES LTD | 7.8¢ | 52.9% |
NSX | NSX LIMITED | 3.2¢ | 45.5% |
ASE | ASTUTE METALS NL | 3.0¢ | 20.0% |
HMD | HERAMED LIMITED | 1.3¢ | 31.6% |
ZMM | ZIMI LIMITED | 0.9¢ | 18.2% |
IVX | INVION LIMITED | 7.9¢ | 16.8% |